menu search

coherus presents data from next-generation immuno-oncology programs at 38th annual meeting of society for immunotherapy of cancer (sitc)

– Data demonstrate distinct IL-27-mediated expression of genes associated with immune suppression in vitro, supporting ongoing clinical development ...

November 3, 2023, 12:30 pm

coherus biosciences to participate at upcoming november investor conferences

REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) — coherus BioSciences, Inc. (“...

November 3, 2023, 12:00 am

coherus biosciences to participate at upcoming november investor conferences

REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- coherus BioSciences, Inc. (“...

November 2, 2023, 8:00 pm

coherus biosciences to report third quarter 2023 financial results on november 6, 2023

REDWOOD CITY, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) — coherus BioSciences, Inc. (“...

October 30, 2023, 10:00 pm

coherus biosciences to report third quarter 2023 financial results on november 6, 2023

REDWOOD CITY, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- coherus BioSciences, Inc. (“...

October 30, 2023, 6:00 pm

Why coherus biosciences stock soared today

coherus and Chinese partner Junshi Biosciences announced U.S. FDA approval of Loqtorzi in all lines of ...

October 30, 2023, 5:43 pm

Intuitive machines stock climbs on lunar mission plan as mcdonald's edges higher ahead of results

coherus BioSciences stock CHRS, -3.65% rose 17% as the Food and Drug Administration approved its treatm...

October 30, 2023, 5:20 am

coherus announces toripalimab data at 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

— Data demonstrate preclinical potent T cell activation and differentiated mechanism of action and enhanced clinical efficacy irrespective of PD-L1 ...

October 14, 2023, 4:30 pm

Why coherus biosciences stock popped today

coherus announced it has resubmitted a biologic license application for one of its products. The FDA ha...

October 5, 2023, 4:45 pm

coherus announces three presentations at the 38th annual meeting of the society for immunotherapy of cancer (sitc)

REDWOOD CITY, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — coherus BioSciences, Inc. (...

September 27, 2023, 1:10 pm

coherus biosciences' new injector treatment for cancer patients rejected by fda

coherus BioSciences said Monday that the U.S. Food and Drug Administration rejected its regulatory subm...

September 25, 2023, 8:53 am

Why coherus biosciences stock was plunging this week

It is about to be deleted from a popular small-cap equity index. As of Monday, Sept....

September 8, 2023, 8:31 am

coherus biosciences to participate at upcoming september investor conferences

REDWOOD CITY, Calif., Sept. 01, 2023 (GLOBE NEWSWIRE) -- coherus BioSciences, Inc. (“...

September 1, 2023, 4:01 pm

Why coherus biosciences stock popped today

The immuno-oncology biotech specialist delivered stronger-than-expected revenue and earnings in Q2. coherus...

August 3, 2023, 7:43 pm

coherus biosciences, inc. (chrs) q2 2023 earnings call transcript

coherus BioSciences, Inc. (NASDAQ:CHRS ) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Com...

August 2, 2023, 11:35 pm

coherus biosciences (chrs) reports q2 loss, tops revenue estimates

coherus BioSciences (CHRS) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus...

August 2, 2023, 6:43 pm

coherus: why i am exiting, but also why you may want to hold on

Here, I discuss my reasons for exiting the stock. My reasons are more or less specific to my situation. Thus, we can agree to disagree without being t...

July 6, 2023, 12:40 pm

coherus biosciences launches biosimilar version of abbvie's blockbuster humira

coherus BioSciences said on Monday it has launched a copycat version of AbbVie's Humira in the United S...

July 3, 2023, 9:12 am

Lifshitz law pllc announces investigations of surf, neti, nex, and pten

NEW YORK, June 24, 2023 (GLOBE NEWSWIRE) — Surface Oncology, Inc. (NASDAQ: SURF) Lifshitz Law PLLC announces an investigation into possible breach o...

June 25, 2023, 12:11 am

Surface oncology stock flies on $65m stock-for-stock acquisition by coherus biosciences

Surface Oncology shares jumped by more than 16% on Friday morning after it was revealed the clinical-stage immuno-oncology (I-O) company is being acqu...

June 16, 2023, 11:01 am


Search within

Pages Search Results: